PI3K Signaling in Single Lymphocytes Analyzed by LMS
PI3K Signaling in Single Lymphocytes Analyzed by LMS
批准号:
6710897
负责人:
DAVID Alexander FRUMAN
金额:
$18.54万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-04-01 至 2006-03-31
关键词:
B cell receptorbiological signal transductioncalcineurinenzyme activityflow cytometrygene targetinggenetically modified animalsimmunomagnetic separationlaboratory mouseleukocyte activation /transformationlymphocytephosphatidylinositol 3 kinaseprotein isoformsprotein kinase Csingle cell analysistissue /cell culture
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Our laboratory studies mechanisms of phosphoinositide 3-kinase (PI3K) signaling in lymphocytes. We are currently funded by grant # 1 RO1-AI50831-01 to determine the specific roles of individual PI3K isoforms in lymphocyte activation. This work relies on standard functional and biochemical assays to characterize lymphocytes from mice lacking specific PI3K isoforms. However, traditional biochemical approaches to measuring signaling enzyme activity have significant limitations, especially when applied to primary lymphocytes. Advances in single cell analysis of signaling events offer powerful tools to advance our understanding of PI3K, as well as other critical signaling systems. In keeping with the developmental emphasis of this R21 mechanism, this application seeks to develop an emerging technology, the laser micropipet system (LMS), to study PI3K-dependent signals at the single cell level. Our first objective is to develop optimal conditions for studying lymphocytes using LMS. Our second aim is to apply this technology to address the role of the PI3K regulatory isoform p85alpha in activation of different downstream signaling molecules.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Repurposing statins to enhance efficacy of BCL-2 antagonists in blood cancer
-
批准号:9178942
-
项目类别:
-
资助金额:$17.85万
-
财政年份:2016
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
Repurposing statins to enhance efficacy of BCL-2 antagonists in blood cancer
-
批准号:9316613
-
项目类别:
-
资助金额:$19.77万
-
财政年份:2016
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
Regulation of B cell differentiation by eIF4E
-
批准号:9244731
-
项目类别:
-
资助金额:$18.37万
-
财政年份:2016
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
Combination strategies to enhance therapy for Ph-like B-ALL
-
批准号:8912208
-
项目类别:
-
资助金额:$25.67万
-
财政年份:2015
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
UCI-GPS: UC Irvine Graduate Professional Success
-
批准号:9341983
-
项目类别:
-
资助金额:$31.79万
-
财政年份:2014
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
UCI-GPS: UC Irvine Graduate Professional Success
-
批准号:8929336
-
项目类别:
-
资助金额:$33.2万
-
财政年份:2014
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
UCI-GPS: UC Irvine Graduate Professional Success
-
批准号:8829529
-
项目类别:
-
资助金额:$34.02万
-
财政年份:2014
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
Solving the elusive mechanism of rapamycin action in lymphocytes
-
批准号:8285697
-
项目类别:
-
资助金额:$19.19万
-
财政年份:2012
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
TOR kinase inhibitors for leukemia therapy: mechanisms of action and resistance
-
批准号:8628792
-
项目类别:
-
资助金额:$30.18万
-
财政年份:2012
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
Solving the elusive mechanism of rapamycin action in lymphocytes
-
批准号:8531852
-
项目类别:
-
资助金额:$21.72万
-
财政年份:2012
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
TOR kinase inhibitors for leukemia therapy: mechanisms of action and resistance
-
批准号:8815271
-
项目类别:
-
资助金额:$31.03万
-
财政年份:2012
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
TOR kinase inhibitors for leukemia therapy: mechanisms of action and resistance
-
批准号:8238745
-
项目类别:
-
资助金额:$32.4万
-
财政年份:2012
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
TOR kinase inhibitors for leukemia therapy: mechanisms of action and resistance
-
批准号:8442848
-
项目类别:
-
资助金额:$29.26万
-
财政年份:2012
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
Immunoregulatory effects of novel mTOR inhibitors
-
批准号:7774553
-
项目类别:
-
资助金额:$7.2万
-
财政年份:2010
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
Immunoregulatory effects of novel mTOR inhibitors
-
批准号:8019056
-
项目类别:
-
资助金额:$7.12万
-
财政年份:2010
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
LIVE CELL IMAGING OF CD4+ T-CELL CHEMOKINESIS OVER IMMOBILIZED CCL21
-
批准号:7724055
-
项目类别:
-
资助金额:$0.35万
-
财政年份:2008
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
PI3K Signaling in Single Lymphocytes Analyzed by LMS
-
批准号:6878064
-
项目类别:
-
资助金额:$22.4万
-
财政年份:2004
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
Phosphoinositide 3-Kinase Function in Lymphocytes
-
批准号:6837137
-
项目类别:
-
资助金额:$34.29万
-
财政年份:2002
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
Phosphoinositide 3-Kinase Function in Lymphocytes
-
批准号:6620748
-
项目类别:
-
资助金额:$34.35万
-
财政年份:2002
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
Phosphoinositide 3-Kinase Function in Lymphocytes
-
批准号:6609015
-
项目类别:
-
资助金额:$2.23万
-
财政年份:2002
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
海外基金